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The mechanism for the post-translational conversion 
of glutamine to pyroglutamic acid on the N terminus 
of newly synthesized peptides and proteins is un- 
known. An assay is reported that permits measurement 
of the rate of conversion of Gln-His-Pro-NH2 to <Glu- 
His-Pro-NH2 (TRH). Using  this  assay,  we demonstrate 
that the spontaneous cyclization of the N-terminal glu- 
tamine of this peptide occurs only  slowly under phys- 
iological conditions. Furthermore, we describe the 
presence in rat brain, porcine pituitary, and  human B 
lymphocytes of an enzyme(s) which converts Gln-His- 
Pro-NHz into <Glu-His-Pro-NHz. The enzyme(s) ap- 
pears to be a glycoprotein, is maximally active at neu- 
tral pH, has a M, of 55,000, and contains catalytically 
significant sulfhydryl groups. The product  of the en- 
zymatic reaction was confirmed by high resolution fast 
atom bombardment-mass spectrometry. 
In preliminary studies, we find that over 90% of the 
enzyme in bovine adrenal medulla is contained in the 
soluble chromaffin vesicle fraction. These findings in- 
dicate that in  vivo the post-translational conversion of 
a glutaminyl-peptide into a pyroglutamyl-peptide is 
neither spontaneous nor abiotic as has been previously 
proposed. 
The  N-terminal  amino acid of many  proteins,  hormones, 
and  neurotransmitter  peptides is pyroglutamic  acid  (5-0xo-L- 
proline). Thyrotropin releasing hormone (TRH, <Glu-His- 
Pro-NH2),l luteinizing hormone releasing hormone (<Glu- 
His-Trp-Ser-Tyr-Gly-Leu-Arg-Pro-Gly-NH2), gastrin,  and 
the heavy chain of y-globulin are examples.  At present,  the 
mechanisms by which  pyroglutamic  acid is  inserted  onto  the 
N terminus of such  proteins  and  peptides  are  unknown.  For 
example,  pyroglutamic  acid can  neither  be  incorporated  into 
tRNA ( I )  nor  inserted directly into a growing peptide (2,  3). 
Although extracts of papaya  latex  can enzymatically cyclize 
Gln-tRNA to <Glu-tRNA (EC 2.3.2.5) (4), <Glu does not 
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possess a reactive amine  and,  therefore, could occupy only the 
amino  terminus of a nascent  peptide  chain, a position  reserved 
for N-formylmethionine  and  the  signal sequence  in secretory 
proteins (5). Thus, for these several reasons and because 
nearly all  secretory  peptides  and  proteins  are  synthesized  as 
part of a  larger precursor,  an  N-terminal pyroglutamyl  moiety 
is believed to  result from the  post-translational modification 
of either  glutamine or glutamic acid. Furthermore,  analysis of 
the  structure of the genes for TRH (6, 7), leuteinizing  hor- 
mone releasing hormone (8), and  the heavy chain of y-glob- 
ulin (9) suggests that glutamine, and not glutamate, is the 
amino acid antecedent of the  N-terminal pyroglutamic acid. 
In 1963, Messer and  Ottesen (10, 11) suggested the presence 
of an enzyme in  crude  papain  that  deamidated  either  gluta- 
mine or glutaminyl peptides to <Glu-peptides (EC 2.3.2.5). 
Over the years, however, because of methodological  difficul- 
ties  in  studying relatively unstable  glutaminyl-peptides,  mam- 
malian  enzymes  catalyzing this  important  post-translational 
modification  have not  yet  been identified (l), and  the  exist- 
ence of such  an enzyme has been  questioned. This  has led to 
the  postulate  that  the  post-translational cyclization of an  N- 
terminal  glutamine  is  spontaneous  and  abiotic  (6).  We now 
present evidence that  the  spontaneous cyclization of an  N- 
terminal glutamine occurs only slowly under physiological 
conditions. We also demonstrate the presence in rat  brain, 
porcine pituitary, bovine adrenal medulla, and  human B lym- 
phocytes of enzyme(s) which convert  Gln-peptides  into  <Glu- 
peptides. 
MATERIALS  AND  METHODS 
Assay for Glutamine Cyche-An assay  for  glutamine  cyclase ac- 
tivity was  developed  based  on the substrate Gln-His-Pro-NHz. Con- 
version of this substrate to the product, <Glu-His-Pro-NHz, was 
measured by radioimmunoassay using an antiserum raised in New 
Zealand  White rabbits  against the immunogen  <Glu-His-Gly-COOH 
(Penninsula Labs, Belmont, CA) coupled through its carboxyl ter- 
minus  to  bovine  serum  albumin at a molar ratio of 20:l by means of 
the water-soluble  carbodiimide,  1-ethyl-3-3-dimethylaminopro- 
pylcarbodiimide.HC1.  Immunization  was  by the multiple  intradermal 
method of Vitakaitis et al. (12). A radioimmunoassay  was  developed 
from this antiserum using lz5I-TRH as tracer, TRH (Penninsula 
Labs,  Belmont, CA) as standard, phosphate-buffered  saline, pH  7.5, 
and  an assay protocol  as  described  elsewhere (13). The within  assay 
and  between  assay  coefficient of variation was 6.1 and 6.7%, respec- 
tively, as determined by the method of Rodbard (14). 
a-N-tBoc-Gln-His-Pro-NH2 was synthesized by standard tech- 
niques  using dicyclohexylcarbodiimide, and its purity  and  amino  acid 
content verified as previously described (15,  16). Gln-His-Pro-NH, 
was  freshly  prepared as needed  by  reaction of the a-N-tBoc-Gln-His- 
Pro-NH2 with 3.5 M HC1 in anhydrous  dioxane,  followed by drying 
under a stream of nitrogen  and  dissolution of the product in 50 mM 
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MOPS, pH 7.2. The Gln-His-Pro-NHZ, stored in this manner at 
-20 "C, is  stable for 2-3 weeks. 
Fifty pl of enzyme sample in 50 mM MOPS, pH 7.2, were added to 
small glass tubes followed by the addition of 30 pl of a mixture 
containing 10 nmol of Gln-His-Pro-NHz and other additives for 
testing. The samples were covered and incubated for 2  h at 37  "C in 
a  shaking water bath. Blank assays contained boiled tissue samples 
as well as  the tested additives. In addition, samples containing active 
enzyme were also incubated without substrate to verify that the 
product resulted solely from the conversion of Gln-His-Pro-NHz and 
not from an endogenous precursor. The reaction was stopped with 2 
ml of ice-cold water and 10-pl aliquots removed and lyophilized  for 
assay of <Gln-His-Pro-NH2  as described above. For determination 
of the pH  optimum, enzyme fractions were dialyzed against a panel 
of buffers each of which contained 50 mM MOPS, 50 mM MES,  and 
50 mM Tris, and previously adjusted to  the desired pH. 
Preparation of Enzyme-Eighteen g of porcine pituitary (Pel- 
Freeze, Rogers, AK) were homogenized in 40 ml of 50 mM MOPS, 
pH 7.2, frozen, and thawed twice, and further  disrupted with a sonic 
probe. The homogenates were centrifuged at 4 X lo4 X g for 30 min. 
Forty ml of the  supernatant were applied to a column of Sephadex 
G-100 (4.5 X 100 cm) and eluted with 200 mM NaC1, 50 mM MOPS, 
pH 7.2, into 15-ml fractions. Twenty-five ml (27.8 mg) of fractions 
25-42 from the Sephadex G-100 chromatography were loaded onto a 
DEAE-cellulose column (2 X 12 cm) and eluted with 50 mM MOPS, 
pH 7.2, and increasing concentrations of NaCI. Five-ml fractions 
were collected and dialyzed against 40 mM MOPS,  pH 7.2. 
Isoelectric focusing in agarose-Sephadex was by the method of 
Manrique and Lasky (17). Hydrogen ion concentration was measured 
by a surface electrode. Fractions were cut from the slab  and  centri- 
fuged at 32,000 X g to "wring out" the gel. 
For all purification steps,  protein was measured by the method of 
Lowry et al. (18), and 50-pl aliquots were assayed for glutamine 
cyclase activity as described above. Enzyme from neonatal rat brain 
and human B lymphocyte cell lines P3X63Ag8 (secreting) and 
P3X63Ag8 (nonsecreting) was prepared in  an identical manner with 
the exception that isoelectric focusing was not performed. 
Affinity Chromatography-To columns containing 2-3 ml of con- 
canavalin A, lentil lectin, or uncoupled Ultrogel support  (LKB,  Gaith- 
ersburg, MD) were added 1-ml  aliquots of the G-100 enzyme prepa- 
rations. The columns were washed with 4 column volumes of  200 mM 
NaC1, 50 mM MOPS, pH 7.2, and  then with 5 volumes of the same 
buffer containing either 0.2 M a-D-glucopyranoside or 0.2 M a - D -  
mannopyranoside. One-ml fractions were collected and analyzed for 
glutamine cyclase activity as outlined above. Neither 0.2 M D-Gluco- 
pyranoside nor 0.2 M D-mannopyranoside inhibited the enzyme when 
added directly to  the assay. 
Affinity chromatography over 2-3-ml columns of organomercurial- 
agarose (Bio-Rad) was carried out in a similar manner except that 
the columns were eluted with a  gradient of  0-200 mM dithiothreitol 
and the fractions dialyzed before assay against the saline/MOPS 
buffer without dithiothreitol. Control experiments indicated that 85% 
of the enzyme activity could be recovered after incubation with 
dithiothreitol and dialysis. 
Verification of Produe-The specificity of the RIA for product was 
verified by determining the affinity of the antisera for authentic TRH 
and a number of congeners including <Glu-His-Pro-COOH, <Glu- 
His, His-Pro-diketopiperazine, Glu-His-Pro-NHz, and the substrate, 
Gln-His-Pro-NHz.  To verify the identity of the product, 5.62 mg (5  
ml) of the G-100 effluent were incubated with 1.65 pmol of Gln-His- 
Pro-NH,. The reaction was stopped with 100 ml  of ice-cold water and 
immediately applied at 4 "C to a column (1.5 X 12 cm) of Dowex 50 
(cationic, 4% cross-linked) previously equilibrated with 0.05 M sodium 
citrate, pH 6.8. The effluent was monitored by TRH RIA, and 
fractions containing immunoreactive TRH were  pooled. The pooled 
samples were charcoal extracted and purified by reverse-phase high 
performance liquid chromatography using a pyridine/acetic acid/ 
propanol mobile phase, as previously described in detail  (19). Immu- 
noreactive fractions were again pooled, lyophilized, and submitted for 
mass spectrometry or subjected to  TLC . Blanks were carried through 
the same purification steps, and recovery of product and possible 
chemical generation of additional product monitored throughout by 
use of a classical and well characterized RIA for TRH (13). For TLC, 
plates were  developed in CH30H, CHCl,, 38% CH,COOH (4060:20) 
and treated with iodine vapor and  the Pauly reagent. 
Mass spectrometry was performed on a VG 7070 E-Q tandem, high 
resolution instrument (VG Instruments, Stamford, CT) fitted with a 
fast atom bombardment system supplied by the manufacturer. Ap- 
proximately 5 pg of standard or sample were placed on the target 
with thioglycerol(10 pi). The target was bombarded by xenon atoms 
at 8 kEV translational energy while the positively charged secondary 
ions were detected by scanning the mass spectrometer cyclically  over 
the mass range 500-50 daltons at  5-s intervals. Accurate mass meas- 
urements were performed by peak matching at a resolution of 5000 
(10% valley definition) using selected acylcarnitines as reference mass 
standards. 
RESULTS AND DISCUSSION 
The  antiserum developed in this  study  has  an  affinity for 
TRH (2.2 X lo7 M-') over 102-fold higher than for the  sub- 
strate, Gln-His-Pro-NH2, and 20-fold higher than for the 
expected product of a glutaminase,  Gln-His-Pro-NH, (1.16 x 
lo6 M-'). The  antibody does not recognize His-Pro-diketopi- 
perazine (kaff < IO3 M-') and  has  an  affinity for <Glu-His of 
only 4.4 X lo5 "I. Use of this  antibody  permits  measurement 
of the  product,  TRH, in the  presence of substrate  and avoids 
the need for physical separation of Gln-His-Pro-NH, and 
TRH  that  can lead to the spontaneous cyclization of Gln- 
peptides (20). 
Incubation of Gln-His-Pro-NH,! with fractions of porcine 
pituitary  obtained by gel chromatography identified  a region 
(fractions 19-42) that  converted  the  substrate  into  TRH (Fig. 
1). The enzyme appeared  to have  a M ,  of 55,000 as  determined 
by co-chromatography with standards, and its activity was 
maximal a t  a pH of approximately 7.2-7.5 with  a  rapid  loss 
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FIG. 1. Formation of <Glu-His-Pro-NHz (TRH) from Gln- 
His-Pro-NH2 by fractions obtained from gel permeation chro- 
matography of porcine pituitary. In this  and  other figures, see 
"Materials and Methods" for details. 
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FIG. 2. Time course for the formation of <Giu-His-Pro-NH2 
(TRH) from Gln-His-Pro-NHz in the presence (-) and ab- 
sence (- - -) of 50 mM EDTA by 50 pl of a pool of fractions 
25-42 from the gel permeation chromatography shown in 
Fig. 1. Formation of TRH by active aliquots is represented by the 
higher set of two curves (blank values subtracted),  and that formed 










70 - - 
60 - 
- 















400 450 xx) 350 400  450 300 350 400 
T3 
450 
TRH standard (6), and TRH standard + Na thioglycerol (c). 
FIG. 3. Fast atom bombardment-mass spectra of the purified product of the glutaminyl-cyclase (a), 
of activity above pH 8.0 or less than 5.0. The  first several 
fractions of cyclizing activity (19-24) also contained TRH 
degrading enzymes as well. No  fraction formed TRH  in  the 
absence of added  substrate, verifying that   TRH was formed 
only from Gln-His-Pro-NHp and not from an endogenous 
precursor. 
The  formation of <Glu-His-Pro-NHp by  a pool of fractions 
25-42 from the gel chromatography, containing 1.1 mg/ml 
protein  and excluding the  TRH degradative  activity,  as  com- 
pared  with boiled samples of the  same pool is shown in Fig. 
2. In  the boiled tissue  blanks at time zero, there  is a small 
amount of TRH immunoreactivity  present,  representing  the 
minor cross-reactivity between the substrate, Gln-His-Pro- 
NH2, and the antibody used to measure product. Over the 
course of 4 h, however, there is a  very slow, but  measurable 
conversion of the  substrate  into  authentic  TRH (0.07 nmol/ 
h, K (rate constant) = 0.008 h-') in the absence of active 
enzyme. In the  presence of the  active enzyme,  however, the 
initial  rate of production of TRH (active  preparation - blank 
values)  is 160-fold greater, 11.4 nmol/h ( K  = 1.33 h-'), a rate 
enhanced 2-fold by the  addition of 10 mM EDTA.  Thus, in 
the  presence of 10 mM EDTA,  50 p1 (0.055 mg) of the G-100 
pool exhausted 10 nmol of substrate in 2 h,  converting  nearly 
80% into  TRH. 
The  product was verified by three methods: 1) immunolog- 
ical,  2) TLC,  and  3)  mass  spectometry. After  3 h,  assay of the 
product from an incubate containing 5.62 mg of the G-100 
extract yielded 309 pg of TRH immunoreactivity while the 
blank  contained 27.5 pg. Following Dowex chromatography, 
charcoal  extraction,  and high performance liquid chromatog- 
raphy of the  products,  total recovery of TRH from the  exper- 
imental sample was 270 pg when assayed by either  the  N- 
terminal  TRH RIA described  above or by classical TRH RIA 
(13). Because of the  initial  rapid removal of Gln-His-Pro-NHz 
by the Dowex a t  4 "C, no  significant  generation of product 
was observed  in the  samples  during  purification.  Furthermore, 
the purified product  migrated  as a  single, Pauly positive spot 
on silica gel TLC  with  an R p  identical  to  that of an  authentic 
TRH standard. 
Fast  atom  bombardment-mass  spectra of the purified prod- 
uct were characterized by a protonated molecular  ion (MH') 
at  m/z 363 and an intense sodium adduct ([M + Na]') at 
m/z 385 (Fig. 3A). A standard of authentic TRH gave an 
intense MH' ion a t  363 (Fig. 3B). Reanalysis of the  TRH 
standard  in sodium  thioglycerol caused  the  appearance of an 
intense sodium adduct at m/z 385 (Fig.  3C). By peak match- 
ing, the  accurate  mass of the m/z 363  ion in  the  sample was 
determined to be 363.1788 (C16H23N604 requires 363.1776) 
while that of authentic TRH was 363.1769. The single Pauly 
positive spot co-migrating with  standard by TLC,  the negli- 
gible deviation of the measured mass from the required mass 
and  the  common  fast  atom  bombardment-generated MH' and 
[M + Na]' ions  in  sample  and  standard  strongly  support  the 
identity of the  product  as  TRH. 
Further  purification of the Gln-cyclizing preparation from 
porcine pituitary on DEAE-cellulose  produced  two  major 
peaks of enzyme activity (Fig. 4),  the  first  (fractions 18-21, 
0.17 mg  of protein/ml) with  a K,  for Gln-His-Pro-NHp of  0.2 
mM and a specific activity ( VmaJ of  2.3 nmol/yg/h;  and  the 
second (fractions 27-31, 0.28 mg of protein/ml), a K ,  of 0.6 
mM and a specific activity (Vmax) of 1.4 nmol/pg/h. Both 
peaks of activity  obtained from the  DEAE  chromatography 
bound tightly to concanavalin A, lentil lectin, and organo- 
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FIG. 4. Further purification of cyclizing enzyme from por- 
cine pituitary by DEAE-cellulose chromatography. 
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mercurial-agarose, suggesting the presence of sulfhydryls and 
N-linked, glycosidic side chains. 
Cofactor requirements of the two DEAE peaks are very 
similar, both being inhibited by transition metals and N- 
ethylmaleimide, and  stimulated by NaCl and EDTA (Fig. 5). 
The second peak, however, appears to be partially  inhibited 
by dithiothreitol; phenylmethylsulfonyl fluoride; and  diethyl- 
dithiocarbamate whereas the first peak of activity is not. 
Interestingly,  both  are  partially  inhibited by FADH and com- 
pletely inhibited by reduced 6-methvlpterin  and 2 mM 1.10- 
okhophenanthroline  not 
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FIG. 5. Comparison of catalytic properties of the two major 
peaks of cyclizing enzyme partially purified from porcine 
pituitary by DEAE-cellulose chromatography as described 
under ‘Materials and Methods.” Peak 1 represents DEAE frac- 
tions 18-21 (0.17 mg  of protein/ml) and peak 2 represents  fractions 
27-31 (0.28 mg of protein/ml).  Control incubations contained only 
the enzyme preparation and Gln-His-Pro-NHp. Abbreviations: Asc, 
ascorbate; NEM, N-ethylmaleimide; PMSF, phenylmethylsulfonyl 
fluoride; DDC, diethyldithiocarbamate; DTT, dithiothreitol; FAD, 
flavine adenine dinucleotide; 6-MP, 6-methylpterin; 6-MP(r), re- 
duced 6-methylpterin; and THB,, reduced tetrahydrobiopterin. 
shown). The inhibition of the enzyme by 1,lO-orthophenan- 
throline (a planar heterocyclic that coordinates many planar 
transition  metals)  contrasts with the stimulation by EDTA. 
The reasons for this  inhibition  are unclear, but likely relate 
to structural  features that are independent of orthophenan- 
throline’s metal coordinating properties. Whether the minor 
differences observed between the two peaks of catalytic activ- 
ity reflect the presence of two distinct enzymes, different 
chemical forms of the same enzyme ( e g .  differing degrees of 
glycosylation), or the presence of confounding impurities will 
require further study. 
Several peptide analogs were tested at equimolar concen- 
trations (0.2 mM) with the substrate Gln-His-Pro-NH2 for 
inhibition of the two peaks of activity (Fig. 5).  Little or no 
inhibition was observed by the presence of the amino acids 
Asn, Glu, and Gln, or by the dipeptides <Glu-Ala or Gln-Gly. 
Furthermore,  neither cyclopentylamine (2 mM) or cyclopen- 
tanol (2 mM) inhibited the enzymatic reaction (data not 
included in Figure). These  results suggest the possibility that 
the enzyme requires a minimum of two peptide bonds for 
recognition of substrate and that  the enzyme has very low 
affinity for <Glu and related congeners. Interestingly, several 
of the amino acids and dipeptides appeared to enhance the 
activity of the enzyme, especially Peak 1. As yet the mecha- 
nism for this activation is undetermined, but is not due to 
immunologic cross-reactivity between inhibitor and  TRH in 
the RIA. 
Isoelectric focusing of fractions 25-42 pooled from the 
Sephadex G-100 chromatography of porcine pituitary also 
gave two major peaks of enzymatic activity, one with a PI of 
5.7 and  a second, a  PI of 7.2, possibly also indicating micro- 
heterogeneity of the enzyme protein. Overall recovery from 
the agarose-Sephadex slabs, however,  was less than 10%. 
Enzyme partially purified by the same procedures from 
human B lymphocyte cells P3X63AgB (secreting) and 
P3X63AgB 653 (nonsecreting) when chromatographed on 
DEAE-cellulose produced only one major peak of activity 
(0.013 nmol/h/pg, [substrate] = 0.2 mM) that eluted with 250 
mM NaC1. Conversely, DEAE fractionation of neonatal rat 
brains also produced only one major peak of enzymatic activ- 
ity, but which eluted with 100 mM NaCl (0.015 nmol/h/pg, 
[substrate] = 0.2 mM). 
From these studies, it is  likely that during  the  post-trans- 
lational processing of precursors of many secretory proteins 
in the endoplasmic reticulum, Golgi, or secretory vesicle, 
“unmasking” of an N-terminal glutamine is a signal causing 
the enzymatic generation of a pyroglutamyl-peptide. Further 
support  for  this proposal is the observation that over 90% of 
the glutamine-peptide cyclase found in bovine adrenal me- 
dulla is contained within the soluble chromaffin vesicle frac- 
tion.’ We conclude, therefore, that  the cyclization of an N- 
terminal glutamine is not  a random, spontaneous event, but 
an enzymatically driven reaction the control of which is 
biologically advantageous. Finally, if this enzyme is of impor- 
tance in the post-translational processing of secretory pep- 
tides  and  proteins,  then  these  results also suggest the presence 
of as yet undiscovered biologically active <Glu-peptides in 
adrenal medulla and  pituitary. 
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